A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Completed · Phase 1

Conditions studied: HIV Infections, Pregnancy

In brief

The purpose of this study is to see if giving nelfinavir (NFV) plus zidovudine (ZDV) plus lamivudine (3TC) to HIV-positive pregnant women and their babies is safe. This study will also look at how long these drugs stay in the blood. ZDV has been given to mothers in the past to reduce the chances of passing HIV on to their babies. However, better treatments are needed to further reduce these chances and to better suit the treatment needs of mothers and their children. Taking a combination of anti-HIV drugs during pregnancy may be an answer.

Key facts

Study ID

NCT00000887

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

People needed

24

Expected to finish

2004-07-01

Last updated by the study team

2021-10-29

Who can join

Age: 13 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients may be eligible for this study if they:
• Are at least 13 years old (need consent of parent or guardian if under 18).
• Are HIV-positive.
• Are in the 2nd or 3rd trimester (14 to 34 weeks pregnant) and are pregnant with one or two children.
• Have a normal ultrasound exam.

You may not qualify if…

• Patients will not be eligible for this study if they:
• Cannot take ZDV or 3TC.
• Have an active opportunistic (HIV-associated) or bacterial infection, or a severe medical condition.
• Have severe diarrhea.
• Are at risk for premature birth or pregnancy complications.
• Have a family history of phenylketonuria (PKU).
• Plan to breast-feed.
• Abuse alcohol or drugs.
• Cannot visit the same clinic for the duration of the study.
• Have taken certain anti-HIV drugs.

Where it is running

• Usc La Nichd Crs — Los Angeles, California, United States
• Tulane Univ. Health Science Ctr., Tulane Univ. Hosp. & Clinic — New Orleans, Louisiana, United States
• Tulane/LSU Maternal/Child CRS — New Orleans, Louisiana, United States
• Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases — Baltimore, Maryland, United States
• HMS - Children's Hosp. Boston, Div. of Infectious Diseases — Boston, Massachusetts, United States
• UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases — Chapel Hill, North Carolina, United States
• St. Christopher's Hosp. for Children — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.